CymaBay Therapeutics (CBAY) – FDA
-
CymaBay Therapeutics (CBAY) Announces EMA Acceptance of Marketing Authorization Application for Seladelpar
-
CymaBay Therapeutics (CBAY) Announces Publication of Positive Phase 3 RESPONSE Data of Seladelpar
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CBAY Stock Lookup